Results 251 to 260 of about 1,390,034 (354)

Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito, Chiara Meneghini, Alice Galli, Luca Gallo, Pierfrancesco Mitrotti, Paola Dimartino, Marianna Inglese, Cinzia Zatti, Alessandro Lupini, Andrea Pilotto, Alessandro Padovani, Micol Avenali, Enza Maria Valente, Cristina Tassorelli, Silvia P. Caminiti   +14 more
wiley   +1 more source

Impact of Monomer Selection and Behavior on Transdermal Drug Delivery Systems: Regulatory and Formulation Perspectives. [PDF]

Cureus
Modi P, Modasiya J, Desai D.
europepmc   +1 more source

Survey on Stability of Pharmaceutical Products in National List of Essential Drugs Used in Hospitals in Thailand

, 1999
C Rakwatin, D Nitysuddi, L Premjit, R Kovithvattanaphong, Yaowalak Wattanapisit, O Tanunkat   +5 more
openalex   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

Bridging bioactive metabolites of <i>Phoenix dactylifera</i> L. with advanced nanocarrier technologies for mucoadhesive drug delivery. [PDF]

Front Pharmacol
Ahmed AH, Gangurde AB, Hussain T, Atalay A, Bender O, Anwar S.   +5 more
europepmc   +1 more source

Analysis of the stability of dose-banding cytotoxic drugs for a clinical developpement with ethical and economic implications

Mélanie Closset
openalex   +1 more source

B-303 Stability of Antipsychotic Drugs in Patient Serum and Plasma Clinical Samples [PDF]

M S Konrath, Adrienne Drisgill, Daniel Kozo, Michelle L. Hilaire, S. J. Salamone   +4 more
openalex   +1 more source

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown, Giulia Carli, Prabesh Kanel, Stiven Roytman, Jaimie Barr, Nicolaas I. Bohnen, Roger L. Albin   +6 more
wiley   +1 more source

Cu-based metal-organic frameworks: synthesis, biomedical applications, and beyond. [PDF]

Discov Nano
Sonwane SM, Ingle RG.
europepmc   +1 more source

[Drug stability].

Vojnosanitetski pregled, 1978
openaire   +1 more source